Prof. Dr. TAMER ZEREN

Yayın Ağı

Makaleler 20

1. Application of the nonlinear methods in pneumocardiogram signals

Yılmaz N., Akıllı M., ÖZBEK M., ZEREN T., Akdeniz K. G.

Journal of Biological Physics , cilt.46, sa.2, ss.209-222, 2020 (SCI-Expanded, Scopus)

2. Significance of using a nonlinear analysis technique, the lyapunov exponent, on the understanding of the dynamics of the cardiorespiratory system in rats

ZEREN T., ÖZBEK M., KUTLU N., Akilli M.

Turkish Journal of Medical Sciences , cilt.46, sa.1, ss.159-165, 2016 (SCI-Expanded, Scopus, TRDizin)

3. Significance of apoptosis related proteins on malignant transformation of ovarian tumors: A comparison between Bcl-2/Bax ratio and p53 immunoreactivity

ZEREN T., Inan S., VATANSEVER H. S., Sayhan S.

Acta Histochemica , cilt.116, sa.8, ss.1251-1258, 2014 (SCI-Expanded, Scopus)

4. Transdisciplinary training between physics and biology led to the development of the hydrodynamics laws

ZEREN T.

CBE Life Sciences Education , cilt.12, sa.4, ss.584-585, 2013 (SCI-Expanded, Scopus)

5. A physical model of the thermodilution method: Influences of the variations of experimental setup on the accuracy of flow rate estimation

ÖZBEK M., ÖZEL H. F., Ekerbiçer N., ZEREN T.

Biomedizinische Technik , cilt.56, sa.1, ss.59-64, 2011 (SCI-Expanded, Scopus)

6. The effects of DBcAMP on the expression of eNOS, iNOS and TGF-beta in rat heart tissue

Ekerbicer N., İNAN S., Tarakci F., ZEREN T.

Biotechnic and Histochemistry , cilt.84, sa.2, ss.47-54, 2009 (SCI-Expanded, Scopus)

7. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: A comparison between EGF-R and TGF-α

ZEREN T., Inan S., Seda Vatansever H., Ekerbicer N., Sayhan S.

Acta Histochemica , cilt.110, sa.3, ss.256-263, 2008 (SCI-Expanded, Scopus)

8. Sensitively recorded breathing signals of rats and their nonlinear dynamics

ZEREN T., ÖZBEK M., Ekerbiçer N., YALÇIN G. Ç., AKDENİZ K.

Journal of Biochemical and Biophysical Methods , cilt.70, sa.4, ss.573-577, 2007 (SCI-Expanded, Scopus)

9. Physical and biological sciences meet in an equation: "Bernoulli" Fizik ve biyolojik bilimlerin buluştuǧu bir denklem: "Bernoulli"

ZEREN T., Ekerbiçer N.

SENDROM , cilt.18, sa.7, ss.61-63, 2006 (Scopus)

10. Tyrosine kinase inhibition and chemotherapy Tirozin kinaz i̇nhibisyonu ve kemoterapi

ZEREN T., Ekerbiçer N.

SENDROM , cilt.16, sa.4, ss.45-48, 2004 (Scopus)

11. Testosterone and nonverbal intelligence in right-handed men with successful and unsuccessful educational levels

KUTLU N., Ekerbicer N., ARI Z., Uyanik B., Zeren T., Tan U.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.111, sa.1-2, ss.1-9, 2001 (SCI-Expanded, Scopus)

12. Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the Anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase

Ek O., Gaynon P., Zeren T., Chelstrom L., Myers D., Uckun F.

LEUKEMIA & LYMPHOMA , cilt.31, sa.1-2, ss.143-149, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. In vivo toxicity and pharmacokinetic features of B43(anti-CD19)-Genistein immunoconjugate

Ek O., Yanishevski Y., Zeren T., Waurzyniak B., Gunther R., Chelstrom L., et al.

LEUKEMIA & LYMPHOMA , cilt.30, sa.3-4, ss.389-394, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. In vivo toxicity, pharmacokinetics, and anticancer activity of genistein linked to recombinant human epidermal growth factor

Uckun F., Narla R., Zeren T., Yanishevski Y., Myers D., Waurzyniak B., et al.

CLINICAL CANCER RESEARCH , cilt.4, sa.5, ss.1125-1134, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells

Uckun F., Narla R., Jun X., Zeren T., Venkatachalam T., Waddick K., et al.

CLINICAL CANCER RESEARCH , cilt.4, sa.4, ss.901-912, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. In vivo toxicity and pharmacokinetic features of B43 (Anti-CD19)-Genistein immunoconjugate in nonhuman primates

Messinger Y., Yanishevski Y., Ek O., Zeren T., Waurzyniak B., Gunther R., et al.

CLINICAL CANCER RESEARCH , cilt.4, sa.1, ss.165-170, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. In vivo toxicity, pharmacokinetic features and immunogenicity of B43 (ANTI-CD19)-genistein immunoconjugate in mice and non-human primates.

Messinger Y., Yanishevski Y., Ek O., Zeren T., Waurzyniak B., Gunther R., et al.

BLOOD , cilt.90, sa.10, ss.1467, 1997 (SCI-Expanded, Scopus)

18. In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin

Waurzyniak B., Schneider E., Tumer N., Yanishevski Y., Gunther R., Chelstrom L., et al.

CLINICAL CANCER RESEARCH , cilt.3, sa.6, ss.881-890, 1997 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: A children's cancer group study

Uckun F., Yang Z., Sather H., Steinherz P., Nachman J., Bostrom B., et al.

BLOOD , cilt.89, sa.10, ss.3769-3777, 1997 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Pharmacokinetic features, immunogenicity, and toxicity of B43(anti-CD19)-pokeweed antiviral protein immunotoxin in cynomolgus monkeys

Uckun F., Yanishevski Y., Tumer N., Waurzyniak B., Messinger Y., Chelstrom L., et al.

CLINICAL CANCER RESEARCH , cilt.3, sa.3, ss.325-337, 1997 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 10

1. Lyapunov Exponents and Frequency Domain Analysis (FFT) of Heart Rate Time Series in Both Spontaneously Breathing and Artificially Ventilated Mice

ÖZBEK M., KAZDAĞLI H., ZEREN T., ÖZEL H. F., AKILLI M., YILMAZ N.

Turkish Physical Society 34th International Physics Congress, MUĞLA-BODRUM, Türkiye, 05 Eylül 2018, cilt.2042, ss.519, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

415

H-İndeks (WoS)

Atıf (Scopus)

434

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler